BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  Avinger Announces 510(k) Filing of Next Generation Pantheris Device

  Avinger announced the Company submitted a new 510(k) application to the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of PAD.

  December 21, 2017

   · 

  4 min read
• Business

  Related Beal Announces Partnership With Mass Innovation Labs to Build on Life Sciences Legacy at Innovation SQUARE

  Related Beal, prominent real estate developer, owner and operator in Boston, today broke ground on a major new addition to Boston’s expanding life sciences cluster in the Raymond L. Flynn Marine Park and announced its first tenant.

  December 21, 2017

   · 

  4 min read
• Pharm Country

  Boehringer Ingelheim Release: New Documentary Film Shines Light on Physical and Emotional Impact of COPD

  The film was created by Emmy-nominated director Abbey LeVine in collaboration with Boehringer Ingelheim Pharmaceuticals.

  December 21, 2017

   · 

  11 min read
• Business

  AIT Bioscience Welcomes New Chief Scientific Officer

  Anderson replaces Ronald E. Shoup, Ph.D. in this role.

  December 21, 2017

   · 

  2 min read
• Immunovia Release: Sahlgrenska University Hospital First Swedish Site in the Largest Ever Prospective Clinical Study for Early Detection of Pancreatic Cancer

  Immunovia today announced that Sahlgrenska University Hospital is the first Swedish site to be part of PanFAM-1, a multicenter prospective validation study for the early diagnosis in familiar pancreatic cancer high risk individuals.

  December 21, 2017

   · 

  3 min read
• Genetown

  bluebird bio to Present at Investor Conferences in January

  Goldman Sachs 10th Annual Healthcare CEOs Unscripted, Thursday, January 4, at 3:15 p.m. ET at the InterContinental, Boston, Massachusetts.

  December 21, 2017

   · 

  3 min read
• Drug Development

  Ra Pharmaceuticals Initiates Dosing in Phase II Clinical Trial Evaluating RA101495 SC in Generalized Myasthenia Gravis Patients

  Ra Pharmaceuticals announced that it has initiated dosing in the Company’s Phase 2 clinical trial evaluating RA101495 SC for the treatment of generalized myasthenia gravis (gMG).

  December 21, 2017

   · 

  6 min read
• Drug Development

  Moleculin Announces Polish Approval for Leukemia Clinical Trial

  Moleculin Biotech announced that the Ethics Committee in Poland has approved the Company’s Phase I/II clinical trial of Annamycin for the treatment of relapsed or refractory AML.

  December 21, 2017

   · 

  3 min read
• Drug Development

  BioArctic, a Company in Karolinska Development’s Portfolio, Announces That the Phase IIb Study of BAN2401 in Early Alzheimer’s Disease Continues Toward 18-Month Endpoint

  Karolinska Development announces today that BioArctic’s drug candidate BAN2401 did not meet the criteria for success at a 12-month interim analysis of a Phase IIb study in patients with early Alzheimer’s Disease.

  December 21, 2017

   · 

  1 min read
• Policy

  Emmaus Life Sciences Sickle Cell Treatment Receives Positive Opinion on Pediatric Investigation Plan from European Medicines Agency

  Emmaus Life Sciences announced today that the Paediatric Committee (PDCO) of the European Medicines Agency (EMA) has accepted the company’s pediatric investigation plan (PIP) for its treatment of sickle cell disease.

  December 21, 2017

   · 

  3 min read